Institution statistics

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG - Germany 

This institution has been merged with: DEUTSCHES KREBSFORSCHUNGSZENTRUM.

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:200-300
Total Number of Projects:400-500
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 30
As coordinator: 3
As participant: 22
Sole participant: 5
Coordinator / Participant Ratio: 0.14*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 7.999.949 677.444 1
2018 3.670.836 4.231.223 4.191.269 3 2
2017 9.376.250 4.259.860 5.560.547 2 2
2016 0 3.325.520 224.438 2
2015 0 28.723.668 978.546 4
2009 158.694 0 158.694 1
2008 2.995.295 18.736.931 1.606.438 1 2
2007 0 3.702.750 217.809 1
2006 0 22.532.628 1.281.028 5
2005 1.999.525 987.963 482.235 1 1
2004 0 6.051.460 336.145 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE7
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE6
KAROLINSKA INSTITUTE6
EUROPEAN MOLECULAR BIOLOGY LABORATORY4
UNIVERSITY COLLEGE LONDON4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
EUROPAISCHES LABORATORIUM FUER MOLEKULARBIOLOGIE EMBL3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
INSTITUT CATALA D'ONCOLOGIA3
INSTITUT CURIE3
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV3
MEDIZINISCHE UNIVERSITAET WIEN3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE3
UNIVERSITAETSKLINIKUM HEIDELBERG3
UNIVERSITY OF COPENHAGEN3
UPPSALA UNIVERSITET3
BAYER AKTIENGESELLSCHAFT2
BIOBANKS AND BIOMOLECULAR RESOURCESRESEARCH INFRASTRUCTURE CONSORTIUM2
CANCER RESEARCH UK2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
CONSIGLIO NAZIONALE DELLE RICERCHE2
DANISH CANCER SOCIETY2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
FINNISH CANCER REGISTRY2
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI2
FORSCHUNGSZENTRUM JULICH2
FUNDACIO CENTRE DE REGULACIO GENOMICA2
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON2
INSTITUT GUSTAVE ROUSSY2
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER2
KLINIKUM DER JOHANN WOLFGANG GOETHE UNIVERSITAET2
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN2
LEIDEN UNIVERSITY MEDICAL CENTER2
MARIA SKLODOWSKA CURIE MEMORIAL CANCER CENTER2
SIEMENS2
TECHNISCHE UNIVERSITAET MUENCHEN2
THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL2
THE UNIVERSITY OF SHEFFIELD2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITAET ZUERICH2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITE CLAUDE BERNARD LYON 12
UNIVERSITE DE LIEGE2
UNIVERSITEIT MAASTRICHT2
UNIVERSITEIT UTRECHT2
UNIVERSITY OF LEEDS2
VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW2
VTT TECHNICAL RESEARCH CENTRE OF FINLAND2
WEIZMANN INSTITUTE OF SCIENCE2
"FREDERIC JOLIOT CURIE" NATIONAL RESEARCH INSTITUTE FOR RADIOBIOLOGY AND RADIOHYGIENE NATIONAL CENTER OF PUBLIC HEALTH1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACADEMISCH ZIEKENHUIS LEIDEN1
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
ALLEANZA CONTRO IL CANCRO1
ASOCIATA AER PUR ROMANIA1
AZIENDA SANITARIA REGIONALE1
BABRAHAM BIOSCIENCE TECHNOLOGIES1
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT1
BEATSON INSTITUTE FOR CANCER RESEARCH1
BEDATADRIVEN BV1
BEREICH HUMANMEDIZIN DER GEORG AUGUST UNIVERSITAET GOETTINGEN1
BIODETECTION SYSTEMS BV1
BIOSPACE MESURES1
BOEHRINGER INGELHEIM PHARMA GMBH & CO KG1
CAB INTERNATIONAL1
CENTER OF EXCELLENCE IN MEDICINE AND IT1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE GIE1
CENTRO DE NEUROCIENCIAS DE COIMBRA E BIOLOGIA CELULAR1
CENTRO DI RIFERIMENTO ONCOLOGICO1
CHARLES RIVER DISCOVERY RESEARCH SERVICES GERMANY1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CONSORZIO INTERUNIVERSITARIO LOMBARDO PER L'ELABORAZIONE AUTOMATICA1
CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLOPROTEINE PARAMAGNETICHE1
CSCTIETEEN TIETOTEKNIIKAN KESKUS OY1
DEPARTMENT OF NUCLEAR MEDICINE TECHNICAL UNIVERSITY MUNICH1
DOHANYZAS VAGY EGESZSEG MAGYAR ALAPITVANY1
DOKUZ EYLUL UNIVERSITESI1
DUALTPHARMA1
EATRIS ERIC1
ECOLE NATIONALE SUPERIEURE D'ELECTRONIQUE INFORMATIQUE ET RADIOCOMMUNICATIONS DE BORDEAUX1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
ELI LILLY AND COMPANY LIMITED1
ELSEVIER BV1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM1
ESAOTE1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
EUCODIS1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM1
EUROPEAN NETWORK FOR SMOKING PREVENTION1
EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS1
EUROPEAN RESPIRATORY SOCIETY1
EXPERIMENTELLE PHARMAKOLOGIE UND ONKOLOGIE BERLINBUCH1
F HOFFMANNLA ROCHE1
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR1
FONDAZIONE HUMANITAS PER LA RICERCA1
FONDS NATIONAL DE LA RECHERCHE1
Constancy:

Total number of partners:373

Partner loyalty:
Frequent Partner: (> 2 projects): 60
Rare Partner: 313

Frequent / Rare Partner Ratio: 0.19

Diversity:

Categories:
Category:No:
RTD HORIZONTAL TOPICS10
SOCIAL AND ECONOMIC CONCERNS9
BIOLOGICAL SCIENCES7
PHYSICAL AND EXACT SCIENCES1
AGRICULTURE AND MARINE RESOURC1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-01-014-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening 4-IN THE LUNG RUNparticipant7.999.9499
2018-09-01Quantitative T cell Immunology and Immunotherapy QuanTIIparticipant3.923.65310
2018-07-01Mechanism and vulnerability of BAP1 loss in tumor metastasis VulneraBAP1coordinator171.4611
2018-06-01Redirecting glial progenitor fate to rebuild the injured Brain REBUILDCNScoordinator2.000.0001
2018-06-01Come and Play Science at European Researchers` Night QriUSparticipant307.57010
2018-06-01Exploring cell interactions in the tumor microenvironment with dual ribosome profiling DualRPcoordinator1.499.3751
2017-10-01A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology PREDICTparticipant3.860.06018
2017-10-01Detecting, understanding and exploiting intracellular redox signaling relays Redox Relayscoordinator2.006.2501
2017-09-01Centre of Excellence in Digital Health and Personalised Medicine Clinnovaparticipant399.8005
2017-01-01ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 ITCC-P4coordinator7.370.00021
2016-01-01European Regulatory Science on Tobacco:Policy implementation to reduce lung diseases EUREST-PLUSparticipant2.325.54513
2016-01-01Towards outstanding research and training in tumour biology at IMM ReTuBiparticipant999.9753
2015-10-01implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC ADOPT BBMRI-ERICparticipant4.949.44923
2015-09-01Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes B-CASTparticipant5.983.35613
2015-09-01Coordinated Research Infrastructures Building Enduring Life-science services CORBELparticipant14.837.80039
2015-09-01Statistical multi-Omics UNDerstanding of Patient Samples SOUNDparticipant2.953.06313
2009-12-01Influence of oxidants on cell fate determination by use of a GFP coupled redox sensor ROS IN CELL FATEcoordinator158.6941
2008-05-01Developmental molecular pathways in Drosophila as a model for human cancer CANCERPATHWAYScoordinator2.995.2958
2008-04-01Normalisation of immune reactivity in old age from basic mechanisms to clinical application TOLERAGEparticipant7.736.93110
2008-02-01Apoptosis systems biology applied to cancer and AIDS. An integrated approach of experimental biology, data mining, mathematical modelling, biostatistics, systems engineering and molecular medicine APO-SYSparticipant11.000.00024
2007-03-01Polarized Helium Lung Imaging Network PHELINETparticipant3.702.75017
2006-10-15Chromatin structure and plasticity CHROMATIN PLASTICITYparticipant3.457.66812
2006-09-01The intracellular routes of growth factor signalling from the plasma membrane to the nucleus ENDOCYTEparticipant2.630.00011
2006-03-01A European Infrastructure of Ligand Binding Molecules Against the Human Proteome PROTEOMEBINDERSparticipant1.799.98430
2006-02-01Development and application of biomarkers of dietary exposure to genotoxic and immunotoxic chemicals and of biomarkers of early effects, using mother-child birth cohorts and biobanks NEWGENERISparticipant13.594.97625
2006-01-01Bio-informatics grid application for life science BIOINFOGRIDparticipant1.050.0007
2005-05-01Human monoclonal antibodies from a library of hybridomas HYBLIBcoordinator1.999.5255
2005-04-01The impact of key determinants on the current and future burden of cancer in Europe EUROCADETparticipant987.96312
2004-07-01European Molecular Imaging Laboratories EMILparticipant1.46043
2004-06-01Cancer control using populationbased registries and biobanks CCPRBparticipant6.050.00018
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum